Publication
Article
BioPharm International
BioPharm International-06-01-2002Volume15 Issue 6
Stem Cells and Xenotransplantation: Ethics, Patents, and Politics
On 19 April, a group of experts gathered to discuss key issues in the ongoing debate about stem cell research and related issues pertinent to xenotransplantation. Participants were Bill Anthony (moderator) of Orrick, Herrington and Sutcliffe; David J. Earp of Geron Corporation; Liz Howard of Orrick, Herrington and Sutcliffe; Wayne Koberstein of Pharmaceutical Executive; Thomas G. Sanders of MitoKor; and Margaret R. McLean of the Markkula Center for Applied Ethics, Santa Clara University.
Articles in this issue
Negotiating and Structuring Strategic Alliances
Finding Funding in Biotechnology: Keeping the Companies Alive
Biotechnology Patent Holders Beware! A Supreme Court Ruling may Significantly Reduce the Value of Your Patent Portfolio
Guest Editorial: Enabling Collaboration in the Pharmaceutical Industry
Stem Cells and Xenotransplantation: Ethics, Patents, and Politics
Unlocking the Value of R&D: Managing the Risks
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
